EWP
EMN icon

Elevation Wealth Partners’s Eastman Chemical EMN Stock Holding History

Elevation Wealth Partners’s Portfolio EMN Stock Details EMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-109
Closed -$8.32K – 1320
2026
Q1 		$8.32K Buy
+109
New +$7.86K ﹤0.01% 565
2025
Q4 		– Sell
-8
Closed -$505 – 978
2025
Q3 		$505 Buy
+8
New +$558 ﹤0.01% 811

Other funds holding EMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Elevation Wealth Partners's EMN Position: Q2 2026 in Review

Elevation Wealth Partners sold out of Eastman Chemical (EMN) in Q2 2026, closing a stake of 109 shares — an estimated $8.32K sold.

Elevation Wealth Partners first reported a position in EMN in Q3 2025 and held it in 2 quarters. The position peaked at $8.32K in Q1 2026. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Elevation Wealth Partners reported no remaining Eastman Chemical position as of Q2 2026 after selling out during the quarter.
  • Elevation Wealth Partners sold 109 Eastman Chemical shares in Q2 2026, an estimated $8.32K.
  • Elevation Wealth Partners first reported a position in Eastman Chemical in Q3 2025 and held it in 2 quarters.
  • Elevation Wealth Partners's Eastman Chemical position peaked at $8.32K in Q1 2026.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.